Elysee Development Corp. — Regulatory Filings 2022

Nov 26, 2022

FORM 51-102F3 Material Change Report Section 7.1 of National Instrument 51-102 Continuous Disclosure Obligations

Item 1.Item 2.Item 3.Item 4.

Name and Address of CompanyElysee Development Corp.9thFloor - 1021 West Hastings StreetVancouver, B.C. V6E 0C3 Date of Material ChangeNovember 25, 2022News ReleaseThe news release was disseminated on November 25, 2022 through the facilities of Newsfile and wasSEDAR filed with the securities commissions of Alberta and British Columbia.Summary of Material ChangeOn November 25, 2022, Elysee Development Corp. announced that all matters submitted to theshareholders, as set out in the Notice of Meeting and Information Circular provided, were approved atthe Company’s Annual General and Special Meeting held in Vancouver, B.C. on November 23, 2022.The shareholders re-elected Guido Cloetens (Chair), Stuart Rogers, Martin Burian and Gaston J.Reymenants as directors of the Company for the forthcoming year.

Shareholders also approved the company’s omnibus equity incentive plan as well as the appointment of Lancaster & David, Chartered Professional Accountants, as the auditor of the Company for the ensuing year, with their renumeration to be fixed by the board of directors.

Item 5. Full Description of Material Change On November 25, 2022, Elysee Development Corp. announced that all matters submitted to the shareholders, as set out in the Notice of Meeting and Information Circular provided, were approved at the Company’s Annual General and Special Meeting held in Vancouver, B.C. on November 23, 2022. The shareholders re-elected Guido Cloetens (Chair), Stuart Rogers, Martin Burian and Gaston J. Reymenants as directors of the Company for the forthcoming year.

Item 6.Item 7.Item 8.Item 9.

Shareholders also approved the company’s omnibus equity incentive plan as well as the appointment ofLancaster & David, Chartered Professional Accountants, as the auditor of the Company for the ensuingyear, with their renumeration to be fixed by the board of directors.Reliance on subsection 7.1(2) or (3) of National Instrument 51-102N/AOmitted InformationN/AExecutive OfficerGuido CloetensTelephone: (778) 373-1562Date of ReportNovember 25, 2022

– 2 –

Caution Regarding Forward-Looking Statements

This news release contains certain forward-looking statements that are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward-looking statements, oral or written, made by itself or on its behalf, except as required by applicable law.